 Mont-Saint-Guibert, Belgium July 2, 2021, 2:40pm CET 8:40am ET Nyxoah SA Euronext BrusselsNasdaq: NYXH Nyxoah or the Company, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea OSA, today announced the pricing of its initial public offering in the United States the Offering of 2,835,000 ordinary shares at a price to the public of US 30 per share for total gross proceeds of US 85.1 million before deducting underwriting discounts and commissions and estimated offering expenses. 